Morocco has spent no less than 6 billion dirhams for the acquisition of vaccines against the coronavirus. This sum was taken from the Special Fund for the Management of the Covid-19 Pandemic.
If Morocco has been praised around the world for its strategy of rapid management of the coronavirus health crisis from the onset of the first cases in the country, this method has nevertheless had a considerable cost for the Moroccan economy.
In addition to the shortfall in recent months due to an economy at a standstill since the pandemic broke out, the management of the health crisis has asked the authorities to invest massively and quickly to save the situation and combat the spread of the virus.
Thus, Morocco has spent, until last September, the sum of 6 billion and 79 million dirhams for the purchase of vaccines against the coronavirus. The Kingdom opted for the Sinopharm and Astrazeneca vaccines early on, before purchasing doses of the Johnson & Johnson vaccine, and before more recently receiving Pfizer-BioNTech.
The Moroccan authorities got involved in ordering vaccines very early on, at a time when stocks were very limited at the global level, hence a campaign that quickly started and very high vaccination figures, the best on the African continent, according to the World Health Organization.
And to allow the greatest number of Moroccans to be vaccinated in order to achieve collective immunity, the Moroccan authorities have made vaccination a free operation. The funds allocated to this campaign were taken from the Special Fund for the management of the pandemic created in March 2020.
The latter reached an amount of 34 billion dirhams, coming from donations from the private sector, citizens and the state budget. Expenses amounted to 29 billion dirhams in 2020.
For the rehabilitation of the health sector during the pandemic, 3 billion and 200 million dirhams were mobilized for 2020 and 2021. This amount was made available to the Ministry of Health for the acquisition of hospital equipment. , drugs (especially chloroquine and hydroxy-chloroquine), pharmaceuticals, etc.
In addition, part of the Fund was devoted to support for the production of non-woven masks for non-medical use, as well as the management of severe cases of the coronavirus which required oxygen, resuscitation beds and care. individuals.
Finally, one of the most important parts of this Fund, was intended to support families plunged into precariousness because of the confinement and the effects of the coronavirus crisis.